Review



enac γ subunit s cterminus  (StressMarq)


Bioz Verified Symbol StressMarq is a verified supplier
Bioz Manufacturer Symbol StressMarq manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    StressMarq enac γ subunit s cterminus
    Enac γ Subunit S Cterminus, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 151 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac γ subunit s cterminus/product/StressMarq
    Average 94 stars, based on 151 article reviews
    enac γ subunit s cterminus - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    StressMarq enac γ subunit s cterminus
    Enac γ Subunit S Cterminus, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac γ subunit s cterminus/product/StressMarq
    Average 94 stars, based on 1 article reviews
    enac γ subunit s cterminus - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    StressMarq enac γ subunit s c terminus
    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of <t>ENaC's</t> γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)
    Enac γ Subunit S C Terminus, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac γ subunit s c terminus/product/StressMarq
    Average 94 stars, based on 1 article reviews
    enac γ subunit s c terminus - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    StressMarq enac γ subunit
    The γENaC-G532S mutation decreases the <t>ENaC</t> sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.
    Enac γ Subunit, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac γ subunit/product/StressMarq
    Average 94 stars, based on 1 article reviews
    enac γ subunit - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    StressMarq gamma subunit epithelial sodium channel
    The γENaC-G532S mutation decreases the <t>ENaC</t> sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.
    Gamma Subunit Epithelial Sodium Channel, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gamma subunit epithelial sodium channel/product/StressMarq
    Average 94 stars, based on 1 article reviews
    gamma subunit epithelial sodium channel - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Charles River Laboratories stably transfected hek293 cell line expressing human α-, β-, and γ-enac subunits
    The γENaC-G532S mutation decreases the <t>ENaC</t> sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.
    Stably Transfected Hek293 Cell Line Expressing Human α , β , And γ Enac Subunits, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stably transfected hek293 cell line expressing human α-, β-, and γ-enac subunits/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    stably transfected hek293 cell line expressing human α-, β-, and γ-enac subunits - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    StressMarq enac α subunit
    The γENaC-G532S mutation decreases the <t>ENaC</t> sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.
    Enac α Subunit, supplied by StressMarq, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enac α subunit/product/StressMarq
    Average 94 stars, based on 1 article reviews
    enac α subunit - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of ENaC's γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)

    Journal: Physiological Reports

    Article Title: Resistance to doxorubicin‐induced proteinuria and proteolytic activation of ENaC in 129S2 / SvPas mice

    doi: 10.14814/phy2.70667

    Figure Lengend Snippet: Doxorubicin injection in 129S2/SvPasCrl males does not enhance proteolytic cleavage of ENaC's γ subunit. (a) A schematic is shown depicting cleavage sites in ENaC's γ subunit and the antibody used for immunoblot. (b) Immunoblot of ENaC's γ subunit from deglycosylated whole kidney lysates. Each lane represents a kidney lysate from one mouse. (c) Quantification of full‐length γ subunit or cleavage products (normalized to stain‐free gel protein intensity). Full‐length γ subunit and furin‐cleaved C‐terminal fragment abundances increase in doxorubicin‐treated mice compared to untreated controls. Distally cleaved γ subunit protein abundance does not increase significantly. (d) Abundance of the furin‐cleaved or distally cleaved proteolytic fragments relative to the total (full‐length + furin‐cleaved + distally cleaved) γ subunit abundance is not enhanced by treatment with doxorubicin. (Ctrl, control mice untreated with doxorubicin; Doxo, doxorubicin‐treated mice. Numbers in pair‐wise comparisons represent p values, as determined using Student's t ‐test.)

    Article Snippet: Lysates were then subjected to SDS‐PAGE and immunoblot using an antibody directed against the ENaC γ subunit's C‐terminus (StressMarq, #SPC‐405) as previously described (Ray et al., ).

    Techniques: Injection, Western Blot, Staining, Quantitative Proteomics, Control

    The γENaC-G532S mutation decreases the ENaC sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.

    Journal: Frontiers in Medicine

    Article Title: Case Report: Functional investigation of the γENaC G532S mutation presenting as mild PHA-1B3

    doi: 10.3389/fmed.2025.1605057

    Figure Lengend Snippet: The γENaC-G532S mutation decreases the ENaC sodium current. (A) Current traces of αβγENaC-WT (top) and αβγENaC-G532S (bottom) are shown during exposure to the solutions indicated by the horizontal bars, at a holding potential of −80 mV. The left and right representative traces result from the protocol measuring amiloride-sensitive current; middle traces show currents measured during exposure to 5 μg/mL trypsin. The current amplitude scale is the same for the 6 traces, as indicated. (B) Amiloride-sensitive currents (I Na ) measured in oocytes expressing αβγENaC-WT ( n = 31) or αβγENaC-G532S ( n = 57), measured before, during, and after treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (C) Normalized amiloride-sensitive currents. The current amplitudes recorded from a given batch of oocytes were normalized to the average ENaC-WT amplitude of that batch for this analysis. (D) Fold increase in I Na measured after treatment with trypsin: in each oocyte, the amiloride-sensitive current amplitude after trypsin exposure was normalized to that measured before trypsin. (E) Amiloride-sensitive currents (I Na ), peak and plateau, measured during treatment with trypsin. *** p < 0.001, Kruskal–Wallis’s one-way ANOVA test, followed by the Dunn’s multiple comparison test. (F) I peak /I plateau of amiloride-sensitive current during trypsin treatment was calculated in each oocyte by normalizing the transient peak amplitude to the corresponding plateau current. (C,D,F) Mann–Whitney’s U -test was performed for statistical analysis. (B–F) Bars represent the mean ± SEM. Note that all data of this figure are from oocytes injected with RNA encoding the three subunits α, β and γ, αβγENaC-WT or αβγENaC-G532S.

    Article Snippet: ENaC γ subunit , Rabbit , StressMarq , SPC-405D , 1 k.

    Techniques: Mutagenesis, Expressing, Comparison, Injection

    Biochemical analysis of WT and mutant ENaC. (A) Representative Western blot analysis of the total (=membrane-enriched) and the cell surface (biotinylated) fractions expression of each of the ENaC subunits, in oocytes injected with either αβγWT or αβγG532S cRNAs. Bands corresponding to the full-length (FL) or cleaved (Cl) forms of α- and γENaC are indicated. Western blots of the endogenous Na + /K + -ATPase α subunit were performed in parallel for normalization of protein recovery. (B-C) Densitometric quantification of Western blots from three independent experiments. The band intensities are normalized to the corresponding Na + /K + -ATPase band intensities to correct for differences in protein recovery. The values thus obtained for each experiment were normalized with that of the corresponding WT subunit. (B) Band intensities of each of the ENaC subunits in membrane-enriched fractions. (C) ENaC subunit expression from biotinylated fractions.

    Journal: Frontiers in Medicine

    Article Title: Case Report: Functional investigation of the γENaC G532S mutation presenting as mild PHA-1B3

    doi: 10.3389/fmed.2025.1605057

    Figure Lengend Snippet: Biochemical analysis of WT and mutant ENaC. (A) Representative Western blot analysis of the total (=membrane-enriched) and the cell surface (biotinylated) fractions expression of each of the ENaC subunits, in oocytes injected with either αβγWT or αβγG532S cRNAs. Bands corresponding to the full-length (FL) or cleaved (Cl) forms of α- and γENaC are indicated. Western blots of the endogenous Na + /K + -ATPase α subunit were performed in parallel for normalization of protein recovery. (B-C) Densitometric quantification of Western blots from three independent experiments. The band intensities are normalized to the corresponding Na + /K + -ATPase band intensities to correct for differences in protein recovery. The values thus obtained for each experiment were normalized with that of the corresponding WT subunit. (B) Band intensities of each of the ENaC subunits in membrane-enriched fractions. (C) ENaC subunit expression from biotinylated fractions.

    Article Snippet: ENaC γ subunit , Rabbit , StressMarq , SPC-405D , 1 k.

    Techniques: Mutagenesis, Western Blot, Membrane, Expressing, Injection